Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults

被引：17
|
作者：
Liu, Xiaoqiang [1 ]
Li, Yuhua [2 ]
Wang, Zhongfang [3 ]
Cao, Shouchun [2 ]
Huang, Weijin [2 ]
Yuan, Lin [4 ]
Huang, Yi-Jiao [5 ]
Zheng, Yan [1 ]
Chen, Jingjing [4 ]
Ying, Bo [6 ]
Xiang, Zuoyun [4 ]
Shi, Jin [4 ]
Zhao, Jincun [3 ]
Huang, Zhen [4 ]
Qin, Cheng-Feng [5 ,7 ]
机构：
[1] Yunnan Prov Ctr Dis Control & Prevent, Kunming, Yunnan, Peoples R China
[2] Natl Inst Food & Drug Control, Beijing, Peoples R China
[3] Guangzhou Inst Resp Hlth, Resp Med, Guangzhou, Guangdong, Peoples R China
[4] Walvax Biotechnol Co Ltd, Kunming, Yunnan, Peoples R China
[5] Beijing Inst Microbiol & Epidemiol, Acad Mil Med Sci, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China
[6] Suzhou Abogen Biosci Co Ltd, Suzhou, Jiangsu, Peoples R China
[7] Chinese Acad Med Sci, Res Unit Discovery & Tracing Nat Focus Dis, Beijing, Peoples R China
来源：
CELL RESEARCH | 2022年 / 32卷 / 08期
基金：
中国国家自然科学基金; 国家重点研发计划;
关键词：
D O I：
10.1038/s41422-022-00681-3
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：777 / 780
页数：4
相关论文
共 50 条
  • [21] Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
    Gonzalez-Hernandez, Mariana
    Kaiser, Franziska Karola
    Steffen, Imke
    Ciurkiewicz, Malgorzata
    van Amerongen, Geert
    Tchelet, Ronen
    Emalfarb, Mark
    Saloheimo, Markku
    Wiebe, Marilyn G.
    Vitikainen, Marika
    Albulescu, Irina C.
    Bosch, Berend-Jan
    Baumgaertner, Wolfgang
    Haagmans, Bart L.
    Osterhaus, Albert D. M. E.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [22] Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate
    Moros, Alexandra
    Prenafeta, Antoni
    Barreiro, Antonio
    Perozo, Eva
    Fernandez, Alex
    Canete, Manuel
    Gonzalez, Luis
    Garriga, Carme
    Pradenas, Edwards
    Marfil, Silvia
    Blanco, Julia
    Rica, Paula Cebollada
    Sistere-Oro, Marta
    Meyerhans, Andreas
    Cabanas, Teresa Prat
    March, Ricard
    Ferrer, Laura
    VACCINE, 2023, 41 (35) : 5072 - 5078
  • [23] Immunogenicity and Safety of the Spikevax® (Moderna) mRNA SARS-CoV-2 Vaccine in Patients with Primary Humoral Immunodeficiency
    Kralickova, Pavlina
    Jankovicova, Karolina
    Sejkorova, Ilona
    Soucek, Ondrej
    Koprivova, Katerina
    Drahosova, Marcela
    Andrys, Ctirad
    Krejsek, Jan
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2022, 183 (12) : 1297 - 1310
  • [24] Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
    Kandeil, Ahmed
    Mostafa, Ahmed
    Hegazy, Rehab R.
    El-Shesheny, Rabeh
    El Taweel, Ahmed
    Gomaa, Mokhtar R.
    Shehata, Mahmoud
    Elbaset, Marawan A.
    Kayed, Ahmed E.
    Mahmoud, Sara H.
    Moatasim, Yassmin
    Kutkat, Omnia
    Yassen, Noha N.
    Shabana, Marwa E.
    GabAllah, Mohamed
    Kamel, Mina Nabil
    Abo Shama, Noura M.
    El Sayes, Mohamed
    Ahmed, Amira N.
    Elalfy, Zahraa S.
    Mohamed, Bassim M. S. A.
    Abd El-Fattah, Safa N.
    El Hariri, Hazem Mohamed
    Abdel Kader, Mona
    Azmy, Osama
    Kayali, Ghazi
    Ali, Mohamed A.
    VACCINES, 2021, 9 (03) : 1 - 15
  • [25] Safety and immunogenicity of the mRNA-1273 vaccine for SARS-CoV-2 in solid organ transplant recipients
    Figueroa, A. L.
    Priddy, F.
    Stolman, D.
    Siangphoe, U.
    Lasso, I. L.
    de Windt, E.
    Girard, B.
    Azzi, J.
    Eghtesad, B.
    Zhou, H.
    Miller, J. M.
    Das, R.
    SWISS MEDICAL WEEKLY, 2023, 153 : 19S - 20S
  • [26] Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents
    Kamei, Koichi
    Ogura, Masao
    Sato, Mai
    Nishi, Kentaro
    Shoji, Kensuke
    Funaki, Takanori
    Ogimi, Chikara
    Ito, Shuichi
    PEDIATRIC NEPHROLOGY, 2023, 38 (04) : 1099 - 1106
  • [27] Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents
    Koichi Kamei
    Masao Ogura
    Mai Sato
    Kentaro Nishi
    Kensuke Shoji
    Takanori Funaki
    Chikara Ogimi
    Shuichi Ito
    Pediatric Nephrology, 2023, 38 : 1099 - 1106
  • [28] Delivery of Experimental mRNA Vaccine Encoding the RBD of SARS-CoV-2 by Jet Injection
    Kisakov, D. N.
    Kisakova, L. A.
    Sharabrin, S. V.
    Yakovlev, V. A.
    Tigeeva, E. V.
    Borgoyakova, M. B.
    Starostina, E. V.
    Zaikovskaya, A. V.
    Rudometov, A. P.
    Rudometova, N. B.
    Karpenko, L. I.
    Ilyichev, A. A.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2024, 176 (06) : 776 - 780
  • [29] A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
    Wanbo Tai
    Xiujuan Zhang
    Aleksandra Drelich
    Juan Shi
    Jason C. Hsu
    Larry Luchsinger
    Christopher D. Hillyer
    Chien-Te K. Tseng
    Shibo Jiang
    Lanying Du
    Cell Research, 2020, 30 : 932 - 935
  • [30] A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
    Tai, Wanbo
    Zhang, Xiujuan
    Drelich, Aleksandra
    Shi, Juan
    Hsu, Jason C.
    Luchsinger, Larry
    Hillyer, Christopher D.
    Tseng, Chien-Te K.
    Jiang, Shibo
    Du, Lanying
    CELL RESEARCH, 2020, 30 (10) : 932 - 935
12345